Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1971 Jun;34(3):209–218. doi: 10.1136/jnnp.34.3.209

Levodopa's awakening effect on patients with Parkinsonism

Gayle G Marsh 1,2, Charles M Markham 1,2, Robert Ansel 1,2
PMCID: PMC1083453  PMID: 4398342

Abstract

The effects of levodopa on tests measuring auditory and visual perception, auditory, and visual short-term memory, verbal learning, and on attention and concentration were studied in 29 patients with Parkinsonism. Thirty-two control subjects matched with the Parkinsonism patients on age, educational level, and verbal IQ were administered the same tests to control for practice effects. Significant improvement occurred for the Parkinsonism patients in verbal learning (an intermediate memory test) and in auditory perception. These improvements were unrelated to changes in anticholinergic medications, increases in alertness or concentration, lessening of depression, or improved motor ability or control. There was no test evidence of levodopa improving visual perception, short-term auditory or visual memory, alertness or concentration. Thus, there is no objective test evidence for levodopa producing a generalized awakening or an alerting effect in Parkinsonism patients who are intellectually alert and well-orientated. Interpretation of the test findings suggests a specific awakening effect, that of improvement in intermediate memory but not in short-term memory. Overall, the Parkinsonism group scored below the control group on all tests, suggesting that cognitive impairment accompanies Parkinson's disease even in patients who are intellectually intact and well oriented.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asso D. W.A.I.S. scores in a group of Parkinson patients. Br J Psychiatry. 1969 May;115(522):555–556. doi: 10.1192/bjp.115.522.555. [DOI] [PubMed] [Google Scholar]
  2. Cotzias G. C., Papavasiliou P. S., Gellene R. Modification of Parkinsonism--chronic treatment with L-dopa. N Engl J Med. 1969 Feb 13;280(7):337–345. doi: 10.1056/NEJM196902132800701. [DOI] [PubMed] [Google Scholar]
  3. Godwin-Austen R. B., Tomlinson E. B., Frears C. C., Kok H. W. Effects of L-dopa in Parkinson's disease. Lancet. 1969 Jul 26;2(7613):165–168. doi: 10.1016/s0140-6736(69)91417-2. [DOI] [PubMed] [Google Scholar]
  4. Klawans H. L., Jr, Garvin J. S. Treatment of parkinsonism with L-dopa (study of 105 patients). Dis Nerv Syst. 1969 Nov;30(11):737–746. [PubMed] [Google Scholar]
  5. Mawdsley C. Treatment of Parkinsonism with Laevo-dopa. Br Med J. 1970 Feb 7;1(5692):331–337. doi: 10.1136/bmj.1.5692.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McDowell F., Lee J. E., Swift T., Sweet R. D., Ogsbury J. S., Kessler J. T. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa). Ann Intern Med. 1970 Jan;72(1):29–35. doi: 10.7326/0003-4819-72-1-29. [DOI] [PubMed] [Google Scholar]
  7. Mindham R. H. Psychiatric symptoms in Parkinsonism. J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):188–191. doi: 10.1136/jnnp.33.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. SATZ P., MOGEL S. An abbreviation of the WAIS for clinical use. J Clin Psychol. 1962 Jan;18:77–79. doi: 10.1002/1097-4679(196201)18:1<77::aid-jclp2270180124>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  9. TALLAND G. A. Cognitive function in Parkinson's disease. J Nerv Ment Dis. 1962 Sep;135:196–205. [PubMed] [Google Scholar]
  10. Warburton J. W. Depressive symptoms in Parkinson patients referred for thalamotomy. J Neurol Neurosurg Psychiatry. 1967 Aug;30(4):368–370. doi: 10.1136/jnnp.30.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Warburton J. W. Memory disturbance and the Parkinson syndrome. Br J Med Psychol. 1967 Jun;40(2):169–171. doi: 10.1111/j.2044-8341.1967.tb00566.x. [DOI] [PubMed] [Google Scholar]
  12. Williams M. The measurement of memory in clinical practice. Br J Soc Clin Psychol. 1968 Feb;7(1):19–34. doi: 10.1111/j.2044-8260.1968.tb00538.x. [DOI] [PubMed] [Google Scholar]
  13. Wycis H. T., Cunningham W., Kellett G., Spiegel E. A. L-dopa in the treatment of post-surgical Parkinson patients. J Neurosurg. 1970 Mar;32(3):281–285. doi: 10.3171/jns.1970.32.3.0281. [DOI] [PubMed] [Google Scholar]
  14. Yahr M. D., Duvoisin R. C., Schear M. J., Barrett R. E., Hoehn M. M. Treatment of parkinsonism with levodopa. Arch Neurol. 1969 Oct;21(4):343–354. doi: 10.1001/archneur.1969.00480160015001. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES